LUP.F - Luye Pharma Group Ltd.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue5,173,3853,814,8422,917,7942,563,129
Cost of Revenue1,123,971851,484535,047475,717
Gross Profit4,049,4142,963,3582,382,7472,087,412
Operating Expenses
Research Development----
Selling General and Administrative2,127,3041,718,1801,388,6651,148,918
Non Recurring----
Others496,976293,912197,206174,025
Total Operating Expenses3,748,2512,863,5762,120,9181,798,660
Operating Income or Loss1,425,134951,266796,876764,469
Income from Continuing Operations
Total Other Income/Expenses Net48,336165,055177,846133,663
Earnings Before Interest and Taxes1,425,134951,266796,876764,469
Interest Expense-170,605-50,467-30,389-15,606
Income Before Tax1,473,4701,116,321974,722898,132
Income Tax Expense167,475135,75680,727133,433
Minority Interest125,616127,513133,458135,570
Net Income From Continuing Ops1,305,995980,565893,995764,699
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income1,303,373981,372891,539754,523
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares1,303,373981,372891,539754,523